302 related articles for article (PubMed ID: 9278394)
21. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
[TBL] [Abstract][Full Text] [Related]
22. Continuing development of acid pump inhibitors: site of action of pantoprazole.
Shin JM; Besancon M; Prinz C; Simon A; Sachs G
Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
[TBL] [Abstract][Full Text] [Related]
23. Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis.
Lambrecht N; Munson K; Vagin O; Sachs G
J Biol Chem; 2000 Feb; 275(6):4041-8. PubMed ID: 10660561
[TBL] [Abstract][Full Text] [Related]
24. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole.
Huber R; Kohl B; Sachs G; Senn-Bilfinger J; Simon WA; Sturm E
Aliment Pharmacol Ther; 1995 Aug; 9(4):363-78. PubMed ID: 8527612
[TBL] [Abstract][Full Text] [Related]
25. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
Bastaki SM; Chandranath I; Garner A
J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
[TBL] [Abstract][Full Text] [Related]
26. Acid secretion and the H,K ATPase of stomach.
Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
[TBL] [Abstract][Full Text] [Related]
28. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
Tomiyama Y; Morii M; Takeguchi N
Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
[TBL] [Abstract][Full Text] [Related]
29. Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans.
Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
Eur J Drug Metab Pharmacokinet; 1998; 23(1):19-26. PubMed ID: 9625268
[TBL] [Abstract][Full Text] [Related]
30. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological aspects of acid secretion.
Hirschowitz BI; Keeling D; Lewin M; Okabe S; Parsons M; Sewing K; Wallmark B; Sachs G
Dig Dis Sci; 1995 Feb; 40(2 Suppl):3S-23S. PubMed ID: 7859583
[TBL] [Abstract][Full Text] [Related]
32. Oligomeric regulation of gastric H+,K+-ATPase.
Morii M; Hayata Y; Mizoguchi K; Takeguchi N
J Biol Chem; 1996 Feb; 271(8):4068-72. PubMed ID: 8626741
[TBL] [Abstract][Full Text] [Related]
33. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
[TBL] [Abstract][Full Text] [Related]
34. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
[TBL] [Abstract][Full Text] [Related]
35. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
Morii M; Takata H; Fujisaki H; Takeguchi N
Biochem Pharmacol; 1990 Feb; 39(4):661-7. PubMed ID: 2154989
[TBL] [Abstract][Full Text] [Related]
36. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
Shin JM; Cho YM; Sachs G
J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
38. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
Morozov IA
Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
[TBL] [Abstract][Full Text] [Related]
39. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
Florent C; Forestier S
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634
[TBL] [Abstract][Full Text] [Related]
40. Inhibitor and ion binding sites on the gastric H,K-ATPase.
Munson K; Garcia R; Sachs G
Biochemistry; 2005 Apr; 44(14):5267-84. PubMed ID: 15807521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]